The landscape of blood sugar treatment is evolving with the emergence of skin-applied GLP-1 therapy. These novel patches offer a potentially less invasive alternative to shots for individuals managing diabetes mellitus type 2 . These patches deliver a GLP-1 agonist directly through the dermis , b